mushroomreferences.com – Page 4 – A Curated List of References Relevant to Physicians, Scientists, and the Intellectually Curious

Erinacine C is a cyathane scaffold-based secondary metabolite, which is naturally produced by the filamentous fungus Hericium erinaceus and has a high potential to treat…

Erinacine C: A novel approach to produce the secondary metabolite by submerged cultivation of Hericium erinaceus

The relationship between mycelial growth and fruit body’s yield of oyster mushrooms (Pleurotus spp.) collected from southern Vietnam

Enhanced growth and yield of oyster mushroom by growth-promoting bacteria Glutamicibacter arilaitensis MRC119

DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites

Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples

Improvement of cognitive functions by oral intake of Hericium erinaceus

Microdosing psychedelics – Does it have an impact on emodiversity?

Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Neuroprotective Effects of Erinacine A on an Experimental Model of Traumatic Optic Neuropathy

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds

Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users-A National Survey Study

Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

The protective effect of erinacine A–enriched Hericium erinaceus mycelium ethanol extract on oxidative Stress–Induced neurotoxicity in cell and Drosophila models of spinocerebellar ataxia type 3

Lower-dose psycholytic therapy – A neglected approach

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway

DARK Classics in Chemical Neuroscience: Psilocybin

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness

Polypore fungus extracts reduce cytotoxicity of cadmium ions in the Hordeum test

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

β-glucan release from fungal and plant cell walls after simulated gastrointestinal digestion

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Psychedelic Drug Legislative Reform and Legalization in the US

Psilocybin in Treatment-Resistant Depression

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants